Abstract
Systemic mastocytosis may be accompanied by a second haematological malignancy, usually of myeloid origin. However, a number of case reports describe systemic mastocytosis coexisting with a second haematological malignancy of lymphoid origin. Here, we report a case of a 74-year-old man with systemic mastocytosis who developed a diffuse large B-cell lymphoma. A short overview of the literature concerning mastocytosis accompanied by a second haematological malignancy is presented.
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Fatal Outcome
-
Humans
-
Lymphoma, Large B-Cell, Diffuse / complications*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Male
-
Mastocytosis, Systemic / complications*
-
Mastocytosis, Systemic / drug therapy
-
Prednisolone / administration & dosage
-
Rituximab
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone